Related Experiment Video

Updated: May 12, 2026

High-speed Video Microscopy Analysis for First-line Diagnosis of Primary Ciliary Dyskinesia
05:32

High-speed Video Microscopy Analysis for First-line Diagnosis of Primary Ciliary Dyskinesia

Published on: January 19, 2022

Early Life Disease Burden and Outcomes in Children Diagnosed With Primary Ciliary Dyskinesia in Infancy

Madhan Kumar1, Dvir Gatt2,3, Zofia Zysman-Colman1

  • 1Montreal Children's Hospital, McGill University Health Centre, Montreal, Quebec, Canada.

Pediatric Pulmonology
|May 11, 2026
PubMed

Insights

Early diagnosis of primary ciliary dyskinesia (PCD) in infants is crucial. Despite early interventions like airway clearance, children face significant respiratory and hearing issues, highlighting the need for ongoing care and further research on therapies like inhaled hypertonic saline.

Area of Science:

  • Pediatric Pulmonology
  • Rare Genetic Disorders
  • Clinical Outcomes Research

Background:

  • Primary ciliary dyskinesia (PCD) is a rare genetic disorder causing chronic oto-sino-pulmonary disease from birth.
  • Delayed diagnosis is common, leading to poorly understood early-life disease burdens.

Purpose of the Study:

  • To analyze early disease burdens and long-term outcomes in infants diagnosed with PCD near birth.
  • To evaluate the impact of early interventions and therapies on disease progression.

Main Methods:

  • Retrospective analysis of disease burdens until age 2 and outcomes at ages 6-7 in infants diagnosed with PCD near birth.
  • Data collected from two Canadian PCD centers.

Main Results:

  • Thirty-five infants (median diagnostic age 34 days) were included; all received chest physiotherapy.
  • By age 2, high rates of respiratory exacerbations (66% outpatient, 29% inpatient), ER visits (60%), and abnormal audiology (91%) were observed.
  • Early inhaled hypertonic saline (IHS) use was associated with less Pseudomonas aeruginosa but more inpatient exacerbations, suggesting a complex effect.

Conclusions:

  • Infants with PCD experience significant respiratory infections and clinical care burdens even with early diagnosis and treatment.
  • A high risk of hearing loss necessitates universal screening and close follow-up.
  • The role of inhaled hypertonic saline in early Pseudomonas acquisition and hospitalization requires further investigation through prospective studies.
Abstract

Keywords:
early outcomeshypertonic salineinfancyneonatal respiratory distressprimary ciliary dyskinesia

More Related Videos

Nasal Brushing Sampling and Processing Using Digital High Speed Ciliary Videomicroscopy – Adaptation for the COVID-19 Pandemic09:03

Nasal Brushing Sampling and Processing Using Digital High Speed Ciliary Videomicroscopy – Adaptation for the COVID-19 Pandemic

Published on: November 7, 2020

In vivo Evaluation of Mucociliary Clearance in Mice06:35

In vivo Evaluation of Mucociliary Clearance in Mice

Published on: December 18, 2020

Related Concept Videos

Chronic Obstructive Pulmonary Disease I: Introduction01:23

Chronic Obstructive Pulmonary Disease I: Introduction

Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic sinusitis...
Chronic Obstructive Pulmonary Disease-I: Introduction01:20

Chronic Obstructive Pulmonary Disease-I: Introduction

Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
Chronic Obstructive Pulmonary Disease01:24

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...